 Foscarnet therapy ganciclovir-resistant cytomegalovirus retinitis patients AIDS Infections cytomegalovirus CMV resistant vitro mumols ganciclovir AIDS patients progressive CMV retinitis chronic ganciclovir therapy patients CMV mumols foscarnet antiviral pyrophosphate analogue patients isolates vitro susceptibility equal mumols patient retinitis progression intervals high-dose intravenous ganciclovir therapy patients therapy cessation viral urine blood foscarnet therapy patients weeks progression foscarnet effective immunocompromised patients progressive CMV retinitis CMV isolates vitro resistance